Bittar, Peter G <br/><br/>
ASFA Category IV becomes Category I: Idiopathic thrombotic thrombocytopenic purpura in a patient with presumed gemcitabine-induced thrombotic microangiopathy.  [electronic resource] 

 -  Journal of clinical apheresis  Jun 2018 
 - 423-426 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1098-1101 
<br/><br/><label>Standard No.: </label>10.1002/jca.21590  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ADAMTS13 Protein--immunology<br/>Deoxycytidine--adverse effects<br/>Diagnosis, Differential<br/>Female<br/>Humans<br/>Middle Aged<br/>Plasma Exchange<br/>Practice Guidelines as Topic<br/>Purpura, Thrombotic Thrombocytopenic--diagnosis<br/>Thrombocytopenia--classification<br/>Thrombotic Microangiopathies--chemically induced<br/>Gemcitabine